Thymalfasin: all 43 studies that test it
Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant TreatmentNot yet recruitingNCT07884201Phase 2
- Thymalfasin for Immune Recovery in Adults With SepsisRecruitingNCT07866118Not applicable
- Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal CancerNot yet recruitingNCT07780721Phase 2
- Thymosin-α1 for Recurrent Implantation FailureRecruitingNCT07675980Phase 2/3
- Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaRecruitingNCT07644897Phase 2
- AI-assisted Subtyping-directed Precision Treatment in Acute Aortic DissectionNot yet recruitingNCT07382375Not applicable
- "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"RecruitingNCT06829355Phase 2
- Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 VaccineRecruitingNCT06821100Phase 1
- Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLCNot yet recruitingNCT06607926Not applicable
- Immuno-effect of Tα1 for Stage I NSCLCRecruitingNCT06598839Not applicable
- Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingNCT06461910Phase 2
- Thymosin Alpha-1 for irAE Secondary to ICIsRecruitingNCT06178146Phase 4
- Thymalfasin-based PRaG Mode for Advanced Refractory Solid TumorsRecruitingNCT05790447Phase 2
- Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal CancerRecruitingNCT05086614Phase 3
- Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis PatientsCompletedNCT04428008Phase 2Results posted
- Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant MelanomaCompletedNCT00911443Phase 2Results posted
- The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLCCompletedNCT06139419Phase 2
- Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal CancerActive, not recruitingNCT06056804Phase 2
- Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary BypassStatus unknownNCT05487469Not applicable
- Zadaxin and HIV-positive Patients With Immune Reconstitution DisorderCompletedNCT04963712Early Phase 1
- Immunotherapy for Elderly Patients With Chronic Osteoporotic PainStatus unknownNCT04524169Phase 4
- Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 InfectionTerminatedNCT04487444Phase 2
- Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung CancerCompletedNCT03659578Phase 2
- The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLFCompletedNCT03082885Not applicable
- First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care TherapyStatus unknownNCT02906163Phase 1/2
- Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for SepsisCompletedNCT02883595Phase 4
- The Efficacy and Safety of Ta1 for SepsisCompletedNCT02867267Phase 3
- Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected PatientsCompletedNCT02646189Phase 1/2
- SBRT Combined With Thymalfasin for Metastatic Esophageal CancerStatus unknownNCT02545751Phase 2
- Abscopal Effect for Metastatic Non-small Cell Lung Cancer.WithdrawnNCT02542930Phase 2
- Abscopal Effect for Metastatic Small Cell Lung CancerWithdrawnNCT02542137Phase 2
- Abscopal Effect for Metastatic Colorectal CancerWithdrawnNCT02535988Phase 2
- Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing PancreatitisCompletedNCT02473406Phase 4
- Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative ResectionStatus unknownNCT02281266Phase 4
- Optimized Treatment and Regression of HBV-induced Compensated Liver CirrhosisCompletedNCT01943617Phase 4
- Optimized Treatment and Regression of HBV-induced Early CirrhosisCompletedNCT01938820Phase 4
- Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.CompletedNCT01178996Phase 3
- A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza VaccineCompletedNCT01031966Phase 2
- Efficacy of Thymosin alpha1 for Severe SepsisCompletedNCT00711620Not applicable
- Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological MalignanciesStatus unknownNCT00580450Phase 1/2
- Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis BCompletedNCT00291616Phase 4
- A Trial of Thymalfasin in Adult Patients With Hepatocellular CarcinomaCompletedNCT00082082Phase 2
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNCT00040027Phase 3